Hospitals Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One® Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis byJosh SandbergFebruary 2, 2017
Hospitals Bone Therapeutics announces further positive efficacy in ALLOB® Phase I/IIA delayed-union fracture trial byJosh SandbergMay 18, 2016
Recon Study supports efficacy of closed reduction, percutaneous fixation of crescent-fracture dislocations byJosh SandbergDecember 23, 2015
